A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

PM Voorhees, RF Manges, Pieter Sonneveld, S Jagannath, G Somlo, A Krishnan, S Lentzsch, RC Frank, S Zweegman, PW Wijermans, RZ Orlowski, B Kranenburg, B Hall, T Casneuf, X Qin, H te Velde, H Xie, SK Thomas

Research output: Contribution to journalArticleAcademicpeer-review

122 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)357-366
Number of pages10
JournalBritish Journal of Haematology
Issue number3
Publication statusPublished - 2013

Cite this